文献速递炎症性肠病

肠上皮Sirtuin 1通过改变肠道微生物群调控小鼠衰老过程中的肠道炎症

Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota.
PubMed 文献 · Gastroenterology · 2017-05-26

研究用肠上皮特异性SIRT1敲除小鼠及对照小鼠,给予DSS诱导急性结肠炎、抗生素清除菌群或考来烯胺螯合胆汁酸,并用16S rRNA测序等分析菌群。SIRT1 iKO小鼠自5-8月龄起潘氏细胞异常活化,22-24月龄出现自发性炎症;抗生素处理可消除炎症。溃疡性结肠炎患者结肠SIRT1 mRNA显著低于对照。

要点

  • 肠上皮SIRT1敲除小鼠自5-8月龄起潘氏细胞异常活化,22-24月龄出现自发性炎症。
  • SIRT1 iKO小鼠自4-6月龄起粪便菌群改变,部分源于胆汁酸代谢改变。
  • 抗生素清除菌群后SIRT1 iKO小鼠22-24月龄无炎症迹象。

核心结论

  • 肠上皮SIRT1通过调控肠道微生物群预防肠道炎症,可能是宿主-微生物相互作用的重要介质。
  • 作者认为设计激活SIRT1的药物可能被开发用于治疗炎症性肠病。

研究设计与样本

  • 研究使用肠上皮特异性Sirt1敲除小鼠(SIRT1 iKO,villin-Cre+,Sirt1flox/flox)与对照小鼠(villin-Cre-,Sirt1flox/flox),背景为C57BL/6。
  • 部分小鼠饮水中加入2.5%葡聚糖硫酸钠连续5-9天诱导急性结肠炎。
  • 部分小鼠饮水中给予抗生素4周以清除菌群;部分小鼠喂食含考来烯胺饲料7天以螯合胆汁酸。
  • 用16S rRNA扩增子测序和定量PCR分析粪便菌群比例;用微阵列和定量PCR比较肠道基因表达谱。
  • 比较年龄匹配的溃疡性结肠炎患者(n=10)与无IBD对照(n=8)结肠组织特定mRNA水平。

主要发现

  • SIRT1 iKO小鼠自5-8月龄起潘氏细胞异常活化,NF-κB和应激通路活化增加,22-24月龄出现自发性炎症,与对照小鼠相比。
  • SIRT1 iKO小鼠自4-6月龄起粪便菌群改变,部分源于胆汁酸代谢改变,与对照小鼠相比。
  • 肠道菌群缺陷的SIRT1 iKO小鼠结肠炎较对照小鼠更严重。
  • 溃疡性结肠炎患者肠道组织SIRT1 mRNA表达水平显著低于对照。
  • 给予抗生素的SIRT1 iKO小鼠在22-24月龄无炎症迹象,且在4-6月龄未较对照小鼠发生更严重结肠炎。

临床怎么用

  • 原文结论未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Intestinal epithelial homeostasis is maintained by complex interactions among epithelial cells, commensal gut microorganisms, and immune cells. Disruption of this homeostasis is associated with disorders such as inflammatory bowel disease (IBD), but the mechanisms of this process are not clear. We investigated how Sirtuin 1 (SIRT1), a conserved mammalian NAD+-dependent protein deacetylase, senses environmental stress to alter intestinal integrity. METHODS: We performed studies of mice with disruption of Sirt1 specifically in the intestinal epithelium (SIRT1 iKO, villin-Cre+, Sirt1flox/flox mice) and control mice (villin-Cre-, Sirt1flox/flox) on a C57BL/6 background. Acute colitis was induced in some mice by addition of 2.5% dextran sodium sulfate to drinking water for 5-9 consecutive days. Some mice were given antibiotics via their drinking water for 4 weeks to deplete their microbiota. Some mice were fed with a cholestyramine-containing diet for 7 days to sequester their bile acids. Feces were collected and proportions of microbiota were analyzed by 16S rRNA amplicon sequencing and quantitative PCR. Intestines were collected from mice and gene expression profiles were compared by microarray and quantitative PCR analyses. We compared levels of specific mRNAs between colon tissues from age-matched patients with ulcerative colitis (n=10) vs without IBD (n=8, controls). RESULTS: Mice with intestinal deletion of SIRT1 (SIRT1 iKO) had abnormal activation of Paneth cells starting at the age of 5-8 months, with increased activation of NF-κB, stress pathways, and spontaneous inflammation at 22-24 months of age, compared with control mice. SIRT1 iKO mice also had altered fecal microbiota starting at 4-6 months of age compared with control mice, in part because of altered bile acid metabolism. Moreover, SIRT1 iKO mice with defective gut microbiota developed more severe colitis than control mice. Intestinal tissues from patients with ulcerative colitis expressed significantly lower levels of SIRT1 mRNA than controls. Intestinal tissues from SIRT1 iKO mice given antibiotics, however, did not have signs of inflammation at 22-24 months of age, and did not develop more severe colitis than control mice at 4-6 months. CONCLUSIONS: In analyses of intestinal tissues, colitis induction, and gut microbiota in mice with intestinal epithelial disruption of SIRT1, we found this protein to prevent intestinal inflammation by regulating the gut microbiota. SIRT1 might therefore be an important mediator of host-microbiome interactions. Agents designed to activate SIRT1 might be developed as treatments for IBDs.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Wellman AS, Metukuri MR, Kazgan N, et al. Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota. Gastroenterology. 2017. PMID: 28552621. doi:10.1053/j.gastro.2017.05.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。